Zobrazeno 1 - 10
of 231
pro vyhledávání: '"E. Brendel"'
Publikováno v:
Campbell Systematic Reviews, Vol 13, Iss 1, Pp 1-144 (2017)
This Campbell systematic review examines the effectiveness of school‐based Mindfulness‐based interventions (MBIs) on cognition, behavior, socio‐emotional outcomes and academic achievement. The review summarizes 61 studies and synthesizes 35 stu
Externí odkaz:
https://doaj.org/article/3838459148274652a58e90a254dd654e
Autor:
Michael W. Burnett, Ariel E. Bobbett, Corinna E. Brendel, Kehaulani Marshall, Christian von Sperber, Elizabeth L. Paulus, Peter M. Vitousek
Publikováno v:
Oecologia. 198:229-242
Autor:
Brandy R. Maynard, Kristen E. Brendel, Jeffery J. Bulanda, David Heyne, Aaron M. Thompson, Therese D. Pigott
Publikováno v:
Campbell Systematic Reviews, Vol 11, Iss 1, Pp 1-76 (2015)
This Campbell systematic review assesses the effects of psychosocial interventions for school refusal. The review summarizes the findings from eight studies. Medium quality evidence shows that cognitive‐behavioural therapy (CBT) increases school at
Externí odkaz:
https://doaj.org/article/cc97e98143d545638037068d8b056184
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Campbell Systematic Reviews, Vol 9, Iss 1, Pp 1-33 (2013)
Externí odkaz:
https://doaj.org/article/4b86f229949a4619bb5825b56c599722
Autor:
Michael W, Burnett, Ariel E, Bobbett, Corinna E, Brendel, Kehaulani, Marshall, Christian, von Sperber, Elizabeth L, Paulus, Peter M, Vitousek
Publikováno v:
Oecologia. 198(1)
Recent studies from the Hawaiian Islands showed that pedogenic thresholds demarcate domains in which rock-derived nutrient dynamics remain similar across wide variations in rainfall. These thresholds appear related to certain aspects of N cycling, bu
Publikováno v:
Campbell Systematic Reviews, Vol 9, Iss 1, Pp 1-33 (2013)
Publikováno v:
2016 IEEE National Aerospace and Electronics Conference (NAECON) and Ohio Innovation Summit (OIS).
The concept of transform sensing was recently proposed to operate radars which consist of multiple antenna elements, for high efficiency and resolution. Using transform sensing, phase delays between and amplitudes of elements are no longer constant a
Publikováno v:
2016 IEEE National Aerospace and Electronics Conference (NAECON) and Ohio Innovation Summit (OIS).
Transform sensing was recently proposed to operate radars with an array of antennas for high efficiency and resolution sensing while covering a large space. Using transform sensing, phases and amplitudes of individual elements are no longer constant
Autor:
O. Christensen, Marja Mergui-Roelvink, E. Brendel, Jan H.M. Schellens, Henk M.W. Verheul, A. Nol-Boekel, B. Loembé, Emile E. Voest, Martijn P. Lolkema, J. Kratzschmar, Marlies H.G. Langenberg, Petronella O. Witteveen, Jeanine M.L. Roodhart
Publikováno v:
Annals of Oncology, 22(11), 2508-2515. Oxford University Press
Langenberg, M H, Witteveen, P O, Roodhart, J, Lolkema, M P, Verheul, H M W, Mergui-Roelvink, M, Brendel, E, Kratzschmar, J, Loembe, B, Nol-Boekel, A, Christensen, O, Schellens, J H & Voest, E E 2011, ' Phase I evaluation of telatinib, a VEGF receptor tyrosine kinase inhibitor, in combination with bevacizumab in subjects with advanced solid tumors ', Annals of Oncology, vol. 22, no. 11, pp. 2508-2515 . https://doi.org/10.1093/annonc/mdq767
Langenberg, M H, Witteveen, P O, Roodhart, J, Lolkema, M P, Verheul, H M W, Mergui-Roelvink, M, Brendel, E, Kratzschmar, J, Loembe, B, Nol-Boekel, A, Christensen, O, Schellens, J H & Voest, E E 2011, ' Phase I evaluation of telatinib, a VEGF receptor tyrosine kinase inhibitor, in combination with bevacizumab in subjects with advanced solid tumors ', Annals of Oncology, vol. 22, no. 11, pp. 2508-2515 . https://doi.org/10.1093/annonc/mdq767
Background Blocking both receptor and ligand of the vascular endothelial growth factor (receptor) VEGF(R) pathway might be feasible and increase antitumor activity. This phase I study investigated telatinib, an oral tyrosine kinase inhibitor targetin